Genome-wide association study identifies novel breast cancer susceptibility loci
read more
Citations
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium
Estrogen receptor-positive breast cancer: a multidisciplinary challenge.
Regulators of gene expression as biomarkers for prostate cancer.
Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms
References
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
A haplotype map of the human genome
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
Identification of the breast cancer susceptibility gene BRCA2
Genomic control for association studies.
Related Papers (5)
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.
Frequently Asked Questions (13)
Q2. What future works have the authors mentioned in the paper "Genome-wide association study identifies novel breast cancer susceptibility loci author" ?
The detection of further susceptibility loci will require genome-wide studies with more complete coverage and using larger numbers of cases and controls, together with the combination of results across multiple studies.
Q3. Why are neighbouring polymorphisms often strongly correlated with each other?
because recombination tends to occur at distinct ‘hot-spots’, neighbouring polymorphisms are often strongly correlated (in ‘linkage disequilibrium’, LD) with each other.
Q4. What is the reason for the low risk of breast cancer?
Known susceptibility genes account for less than 25% of the familial risk of breast cancer, and the residual genetic variance is likely to be due to variants conferring more moderate risks.
Q5. What are the common genes in the breast cancer susceptibility study?
Most previously identified breast cancer susceptibility genes are involved in DNA repair, and many association studies in breast cancer have concentrated on genes in DNA repair and sex hormone synthesis and metabolism pathways.
Q6. What was the method used for the mapping of the FGFR2 locus?
Genotyping for stage 3, and for the fine-scale mapping of the FGFR2 locus, was conducted using either a 5′ nuclease assay (Taqman, Applied Biosystems) or MALDITOF mass spectrometry using the Sequenom iPLEX system.
Q7. How many SNPs can be analysed in association studies?
Recent technological advances have provided platforms that allow hundreds of thousands of SNPs to be analysed in association studies, thus providing a basis for identifying moderate risk alleles without prior knowledge of position or function.
Q8. What is the likelihood of a similar study being required to identify common alleles for other?
As most common cancers have similar familial relative risks to breast cancer, it is likely that similarly large studies will be required to identify common alleles for other cancers.
Q9. How many cases of breast cancer were selected?
The cases were selected to have a strong family history of breast cancer, equivalent to at least two affected female first-degree relatives, because such cases are more likely to carry susceptibility alleles20.
Q10. How many SNPs are found in HapMap?
On the basis of their staged design and the estimated distribution of linkage disequilibrium between the typed SNPs and those in HapMap, the authors estimate that the power to identify the five most significant associations at P<10−7 (rs2981582, rs3803662, rs889312, rs13281615 and rs3817198) was 93%, 71%, 25%, 3% and 1% respectively.
Q11. How many variants need to be subjected to functional analysis?
the use of studies from multiple populations with different patterns of LD can substantially reduce the number of variants that need to be subjected to functional analysis.
Q12. What is the significance of the association between FGFR2 and breast cancer?
It is notable that three of the five loci contain genes related to control of cell growth or to cell signalling, but only one (FGFR2) had a clear priorEaston et al.
Q13. How many SNPs showed some evidence of association in stage 3?
In particular, three SNPs showed some evidence of association in stage 3 (P<0.05, in each case in the same direction as in stages 1Easton et al.